PTC THERAPEUTICS, INC.(PTCT)内部人交易:高管与董事近期交易
过去 18 个月,共有 18 位内部人为 PTC THERAPEUTICS, INC.(PTCT)报告了 384 笔 Form 4 交易(最近一笔 2026-11-18)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-18 | Boulding Mark Elliott | EXEC. VP AND CLO | 买入 | 2,812 | $72,240 |
| 2026-11-18 | Boulding Mark Elliott | EXEC. VP AND CLO | 卖出 | 1,315 | $80,728 |
| 2026-11-18 | Boulding Mark Elliott | EXEC. VP AND CLO | 卖出 | 1,288 | $80,139 |
| 2026-11-18 | Boulding Mark Elliott | EXEC. VP AND CLO | 卖出 | 209 | $13,146 |
| 2026-10-16 | SCHMERTZLER MICHAEL | 董事 | 卖出 | 2,118 | $126,063 |
| 2026-10-16 | SCHMERTZLER MICHAEL | 董事 | 卖出 | 382 | $22,973 |
| 2026-10-13 | Boulding Mark Elliott | EXEC. VP AND CLO | 买入 | 192 | $7,569 |
| 2026-10-13 | Boulding Mark Elliott | EXEC. VP AND CLO | 卖出 | 192 | $12,338 |
| 2026-10-09 | SCHMERTZLER MICHAEL | 董事 | 卖出 | 2,447 | $155,091 |
| 2026-10-09 | SCHMERTZLER MICHAEL | 董事 | 卖出 | 53 | $3,389 |
| 2026-10-07 | Boulding Mark Elliott | EXEC. VP AND CLO | 买入 | 435 | $17,148 |
| 2026-10-07 | Boulding Mark Elliott | EXEC. VP AND CLO | 卖出 | 1,638 | $104,881 |
| 2026-10-07 | Boulding Mark Elliott | EXEC. VP AND CLO | 买入 | 1,638 | $64,570 |
| 2026-10-07 | Boulding Mark Elliott | EXEC. VP AND CLO | 卖出 | 435 | $27,910 |
| 2026-10-02 | STEELE GLENN JR MD PHD | 董事 | 买入 | 12,000 | $134,760 |
| 2026-10-02 | STEELE GLENN JR MD PHD | 董事 | 卖出 | 12,000 | $781,920 |
| 2026-09-18 | SCHMERTZLER MICHAEL | 董事 | 卖出 | 2,994 | $199,341 |
| 2026-09-18 | SCHMERTZLER MICHAEL | 董事 | 卖出 | 7,006 | $471,854 |
| 2026-09-18 | SCHMERTZLER MICHAEL | 董事 | 卖出 | 9,624 | $652,796 |
| 2026-09-18 | SCHMERTZLER MICHAEL | 董事 | 卖出 | 376 | $25,737 |
| 2026-09-11 | SCHMERTZLER MICHAEL | 董事 | 卖出 | 9,428 | $639,124 |
| 2026-09-11 | SCHMERTZLER MICHAEL | 董事 | 卖出 | 572 | $39,279 |
| 2026-09-11 | SCHMERTZLER MICHAEL | 董事 | 卖出 | 10,000 | $673,400 |
| 2026-08-28 | SCHMERTZLER MICHAEL | 董事 | 卖出 | 6,874 | $500,015 |
| 2026-08-28 | SCHMERTZLER MICHAEL | 董事 | 卖出 | 5,626 | $411,711 |
来源:SEC Form 4 申报文件 · 截至 2026-11-18